her2climb study shows efficacy in her2 breast cancer with brain metastases
Published 4 years ago • 456 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:52
her2climb regimen can be used earlier in her2 metastatic breast cancer
-
2:00
survival advantage observed in her2 breast cancer with brain metastasis
-
4:30
tucatinib for the treatment of her2 breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
6:11
understanding her2climb clinical trial
-
0:49
systemic therapies shown to be effective in her2-positive breast cancer
-
5:25
her2climb fda approval
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
0:52
exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
-
3:06
trastuzumab deruxtecan effective against brain metastases in her2-positive breast cancer
-
17:38
2021 west oncology | breast cancer | update on brain metastases
-
31:51
metastatic her2 breast cancer
-
1:37
her2 climb study: stopping cancer’s spread
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
1:42
dr. hamilton on the her2climb trial in metastatic her2 breast cancer
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
4:44
an overview of recent metastatic her2 breast cancer trials